Bullpen.News From Edwin Dorsey
Get Daily Recap Feedback

Latest News

Market cap$300M–$10B
All Over $50MOver $300MOver $2BOver $10B
All Under $1BUnder $10BUnder $100BUnder $500B
SectorsAll
Filter by sector
Thursday, October 15, 2026· 3755 stock ideas· 217 writers·
16,020 views· 7,475 clicks

Problems at Dream Finders Homes (DFH)

Dream Finders Homes’ controlling owner borrowed against DFH stock before the homebuilder agreed to finance an acquisition with costly preferred stock and debt.

DFH $808M
Hunterbrook 6 clicks

From X

@ClarkSquareCap

Clark Square Capital on X

Pretty solid technical backdrop for $LUXE. Short interest still at 4 million shares despite the big recent move. 4m shares short take 20 days to cover and represent almost 20% of the actual float (~23m shares). Then you have the company with a $50m authorization -- which could take out another 5m shares or so at current prices. In total, there could be buying for ~9m shares or ~40% of the float in the next few months. Crazy.
@kevin__mak

Kevin Mak on X

$SPHR Update on my old friend Sphere. The recent sell off seems to be directly related to some sell-side rerating of the stock based on "soft data". I find that kind of interesting because the data has been soft for many months (see daily ticket sales chart below), and among investors that I talk to, this isn't a "surprise". (Realistically that's why the stock traded down from $170 to $130). So this "surprise, the data is weak, stock rerates down 25%" is interesting to me, but also reminds me: it's always extremely hard to figure out what the market has or hasn't "priced in". The issue with the "soft data" is that my (and many) original projections was that WoZ would trough at around 1.4-1.6m/day of sales in 2027. By the summer we observed levels of ~1.2m so that likely wasn't going to happen. Towards the end of the year, the data has inflected upwards, we're down YoY (expected, given less hype than the launch a year ago). Some of this is likely due to LV weakness in general, but I think that's a relatively small fraction of the story. Personally, I find this data interesting because A) I think it's largely meaningless to value the company B) I think the market overreacts to it I think the Sphere business is humming along extremely nicely. The concert business is consistently improving (higher numbers, better acts, more utilization). The ads and bookings businesses are healthy/growing, there are 2 (and probably more unannounced) additional Spheres working through production. What WOZ did was prove that a "hit film" could generate enormous interest/revenues/visitors to the Sphere. Whether it "levels off" at $1m/day, or $1.2m/day or $1.4m/day, doesn't matter that much because the longer term model is to consistently launch NEW films launch and generate $1.5-$2.5m/day. And they have somewhere between 2-3 new films coming out next year, and probably another 2-3 films in 2028. AI is cutting their speed (and cost) of making films dramatically. Overall I'm a buyer at these $100-$120 price levels (We're long via some short Nov $120P's that are currently in the money). Given recent price action, it's hard to say how the market reacts to the November earnings release, but I think the earnings picture has stabilized from here and the stock is setup for good fundamental catalysts driving earnings growth in 2027.

Investor Letters

All letters

Free Recaps of the best new stock ideas, delivered every morning.

Read past recaps

October 2026 Random Ramblings

October 2026 market commentary covers SOLS’s cancelled merger, a hypothetical Starbucks-Chipotle deal, Russell 2000 weakness and AI…

SOLS $9.7B
Yet Another Value Podcast 82 clicks
SRTA · long

Strata Critical Medical INC

Strata Critical Medical, SRTA, supplies organ-transport products tied to U.S. transplant growth.

SRTA $404M
Value Investors Club 3 clicks

LQDA: finer powder, higher doses

Liquidia’s Yutrepia sales reached $170.4 million in Q2 2026, while a patent ruling threatens its PH-ILD label but leaves PAH sales and a…

LQDA $2.4B
Trade Ideas Flow 4 clicks

Deep Dive: Inter & Co

Inter & Co, Brazil’s second-largest neobank, grew over 20% with controlled delinquencies and 15% book-value compounding while trading at…

INTR $3.3B
Capitalist Letters 7 clicks

Have a source we’re missing? Send your pick

Recent recaps

Latest recap

Wednesday, October 14 70 stock ideas
  • October 2026 Random Ramblings Yet Another Value Podcast
  • Visa: Unpacking The 7 Powers And Forward Valuation Ahead Of Q4 Earnings Seeking Alpha
Read the recap

All recaps

Publications we follow

Every publication on this site, hand-picked.

129 publications

Newsletters 107

YouTube 4

Blogs 17

Seeking Alpha 49 of 227

Nominate a publication

X accounts we follow

Every account on this site, hand-picked.

88 accounts
Nominate an account

Investor letters we follow

189 firms

Sectors

Ordered by how often our editor reaches for them.

Anything we’re missing?

Send us a pick